Nutrition Inc. (OTC: ADIA) Stock Soars After A Major LOI To Lease A New Clinic

Yesterday, the Adia Nutrition Inc. (OTC: ADIA) stock was one of the more notable movers in the market after it clocked gains of 34% for the day following a significant new announcement. It could be a good move to take a closer look at the news.

Adia Nutrition Inc. Takes Major Steps Forward: Signs LOI for First Clinic and Engages Legal Expertise for Licensing

The company announced yesterday that it had embarked on a path-breaking new initiative in its quest to tackle multiple sclerosis. Adia Nutrition announced that it had inked a letter of intent for leasing a new clinic located in Winter Park, Florida.

The clinic would offer AHSCT (autologous hematopoietic stem cell transplantation) meant to treat multiple sclerosis and mark a major step forward in customized healthcare. More importantly, this move would be ahead of the company’s initial projections for expansion.

Further Work

However, the company would also need to wade through the regulatory compliance and medical licensing processes before the clinic becomes operational. The company announced that in order to take care of those issues, it contracted the services of Smith Hulsey & Busey, a law firm.

In order to make sure that the clinic operates as per federal, state, and local regulations, Attorney Jeanne Helton would lead the efforts. Additionally, she would also help the company with the requisite medical licenses and in maintaining the highest standards in terms of safety and patient care.

CEO Quote

“We are incredibly excited about this venture into MS treatment through AHSCT,” stated Larry Powalisz, CEO of Adia Nutrition. “Being able to offer this advanced treatment option ahead of schedule is a testament to our team’s dedication and the support from our community. Partnering with Smith Hulsey & Busey, particularly with Jeanne Helton, who has expertise in dealing with health regulatory bodies including the FDA, ensures we adhere to the rigorous standards required in healthcare, providing peace of mind for our patients and stakeholders.”

Traders Notes

+/- EMA(20)	0.0065 (-15.38%)
+/- SMA(50)	0.0077 (-28.57%)
+/- SMA(200)	0.0111 (-50.45%)